A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC).
Alleles
Amino Acid Substitution
DNA Mutational Analysis
Electroretinography
Founder Effect
Genetic Association Studies
Genetic Diseases, Inborn
/ diagnosis
Genetic Predisposition to Disease
Genetic Testing
Geography, Medical
Humans
Inheritance Patterns
Israel
/ epidemiology
Mutation
Population Surveillance
Retinal Diseases
/ diagnosis
Whole Genome Sequencing
Israel
genetic analysis
inherited retinal diseases
mutations
retina
retinitis pigmentosa
Journal
Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
16
04
2019
revised:
21
08
2019
accepted:
22
08
2019
pubmed:
29
8
2019
medline:
20
5
2021
entrez:
29
8
2019
Statut:
ppublish
Résumé
Inherited retinal diseases (IRDs) cause visual loss due to dysfunction or progressive degeneration of photoreceptors. These diseases show marked phenotypic and genetic heterogeneity. The Israeli IRD consortium (IIRDC) was established in 2013 with the goal of performing clinical and genetic mapping of the majority of Israeli IRD patients. To date, we recruited 2,420 families including 3,413 individuals with IRDs. On the basis of our estimation, these patients represent approximately 40% of Israeli IRD patients. To the best of our knowledge, this is, by far, the largest reported IRD cohort, and one of the first studies addressing the genetic analysis of IRD patients on a nationwide scale. The most common inheritance pattern in our cohort is autosomal recessive (60% of families). The most common retinal phenotype is retinitis pigmentosa (43%), followed by Stargardt disease and cone/cone-rod dystrophy. We identified the cause of disease in 56% of the families. Overall, 605 distinct mutations were identified, of which 12% represent prevalent founder mutations. The most frequently mutated genes were ABCA4, USH2A, FAM161A, CNGA3, and EYS. The results of this study have important implications for molecular diagnosis, genetic screening, and counseling, as well as for the development of new therapeutic strategies for retinal diseases.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-149Informations de copyright
© 2019 Wiley Periodicals, Inc.